{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-55-2.15",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 §§ 55-2.15 - Requirements for laboratories performing testing for medical marihuana",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 §§ 55-2.15 - Requirements for laboratories performing testing for medical marihuana\n\nState Regulations\n(a) For purposes of this Subpart, the following terms shall have the following meanings: (1)\n\nMedical marihuana\nshall mean marihuana as defined in subdivision 21 of section\n3302\nof the Public Health Law, intended for a certified medical use, as determined by the commissioner in his or her sole discretion. (2)\n\nMedical marihuana product\nshall mean any material produced from medical marihuana prior to its final packaging, e.g., extracts. (3)\n\nFinal medical marihuana product\nshall mean the final medical marihuana product as dispensed to the patient. Any form of medical marihuana not approved by the commissioner is expressly prohibited. (4)\n\nRegistered organization\nshall mean a for-profit business entity or not-for-profit corporation organized for the purpose of acquiring, processing manufacturing, selling, delivering, transporting, distributing or dispensing medical marihuana in accordance with the requirements of title 5-A of article 33 of the Public Health Law. (b) (1)\n\nPrior to performing testing for any medical marihuana, medical marihuana product or final medical marihuana product, a laboratory physically located within New York State shall submit a request to the department, and receive an initial or revised certificate of approval that includes the specialty of medical marihuana testing and the approved method(s) the laboratory is authorized to employ as stipulated in sections\n55-2.1\nand\n55-2.5\nof this Subpart, in addition to a valid Class 8 Analytical Laboratory license, issued by the department's Bureau of Narcotic Enforcement. The certificate of approval shall also list the specific subcategories, analytes, and approved methods included in the approval. No laboratory shall examine a sample related to medical marihuana without certification of approval specific to this category and meeting all other provisions within this Subpart; and\n(2)\nthe department may withhold or limit its approval if the department is not satisfied that: (i) the laboratory has in place adequate policies, procedures, and facility security (physical and cyber security) to ensure proper: collection; labeling; accessioning; preparation; analysis; result reporting for; and disposal of and storage of medical marihuana, medical marihuana product or final medical marihuana product as defined in section\n55-2.15\n(a) of this Subpart; or\n(ii)\nthe laboratory is able to meet the requirements applicable to it as set forth in title V-A of article 33 of the Public Health Law, and section\n1004.14\nof this Title. (c) In addition to application and attestation requirements found elsewhere in this subpart, a laboratory seeking approval to perform medical marihuana, medical marihuana product or final medical marihuana product testing shall submit: (1)\na standard operating procedure manual documenting laboratory policies, procedures, facilities, equipment, supplies, instrumentation and personnel for medical marihuana, medical marihuana product or final medical marihuana product testing, which are designed to ensure proper: collection; labeling; accessioning; preparation; analysis; result reporting or, disposal of and storage of medical marihuana, medical marihuana product or final medical marihuana product as defined in section\n55-2.15\n(a) of this subpart including any validation summaries or data as requested; and\n(2)\nan attestation signed by the owner(s) and director(s) that, in addition to meeting the preceding requirements of this Subpart, a laboratory engaged in medical marihuana testing, through its owner(s) and director(s), shall: (i) confirm that the laboratory shall accept only the type(s) of samples specified on the laboratory\"\nTM\ns certificate of approval; (ii)\nconfirm that the laboratory owner(s) and director(s) is independent of any owner and employee of a registered organization; and\n(iii)\nconfirm that the owner(s) and director(s) will ensure that all test results are reported in a manner and form consistent with the approved method and with requirements in title V-A of article 33 of the Public Health Law, including but not limited to: (a) reporting of results, as applicable, including regulated analytes as well as any contaminants listed in section\n1004.14\n(g) of this Title to the registered organization and the department using a department approved mechanism; and\n(b) reporting of any improprieties regarding the medical marihuana product testing, including but not limited to, theft and the falsification of any data, documentation, or attestation related to the medical marihuana product testing to the department within two business days from the date of learning of the impropriety. (c) The approval of mobile laboratories is prohibited for the purposes of this section. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\n§§\n55-2.15\n\nAdopted, New\n\nYork State Register April 15, 2015/Volume XXXVII, Issue 15, eff. 4/15/2015\n\nAmended\n\nNew\n\nYork State Register December 27, 2017 /Volume XXXIX, Issue 52, eff. 12/27/2017\n\nAmended\n\nNew\n\nYork State Register August 21, 2019/Volume XLI, Issue 34, eff. 8/21/2019\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 58199
}